Abstract
Brevibacillus expression system is an effective bacterial expression system for secretory proteins. The host bacterium, Brevibacillus choshinensis, a gram-positive bacterium, has strong capacity to secrete a large amount of proteins (∼30g/L), which mostly consist of cell wall protein. A host-vector system that utilizes such high expression capacity has been constructed for the production of secretory proteins and tested for various heterologous proteins, including cytokines, enzymes, antigens, and adjuvants.
Keywords: Brevibacillus choshinensis, host-vector system, secretory production, recombinant protein, gram-positive bacteria
Current Pharmaceutical Biotechnology
Title: Brevibacillus Expression System: Host-Vector System for Efficient Production of Secretory Proteins
Volume: 11 Issue: 3
Author(s): Makoto Mizukami, Hiroshi Hanagata and Akira Miyauchi
Affiliation:
Keywords: Brevibacillus choshinensis, host-vector system, secretory production, recombinant protein, gram-positive bacteria
Abstract: Brevibacillus expression system is an effective bacterial expression system for secretory proteins. The host bacterium, Brevibacillus choshinensis, a gram-positive bacterium, has strong capacity to secrete a large amount of proteins (∼30g/L), which mostly consist of cell wall protein. A host-vector system that utilizes such high expression capacity has been constructed for the production of secretory proteins and tested for various heterologous proteins, including cytokines, enzymes, antigens, and adjuvants.
Export Options
About this article
Cite this article as:
Mizukami Makoto, Hanagata Hiroshi and Miyauchi Akira, Brevibacillus Expression System: Host-Vector System for Efficient Production of Secretory Proteins, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791112031
DOI https://dx.doi.org/10.2174/138920110791112031 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled
Current Molecular Pharmacology The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Current Pharmaceutical Design Synthesis, Characterization and Molecular Docking Studies of Novel N-(benzimidazol-1-ylmethyl)-4-chlorobenzamide Analogues for Potential Anti-inflammatory and Antimicrobial Activity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Eosinophilic Esophagitis: New Pathogenic Insights
Current Immunology Reviews (Discontinued) Lymphoma and the Control of B Cell Growth and Differentiation
Current Molecular Medicine Potential Clinical Applications of Multi-functional Milk Proteins and Peptides in Cancer Management
Current Medicinal Chemistry Viral Elements Sense Tumorigenic Processes:Approaching Selective Cancer Therapy
Mini-Reviews in Medicinal Chemistry Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Current Drug Targets Unveiling mRNA Changes During Meiotic Progression and Pre-Implantation Development: Help from Large Animal Models
Current Pharmaceutical Design Immunomodulating Anticancer Alkylating Drugs: Targets and Mechanisms of Activity
Current Drug Targets Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics Transcriptional and Post-Transcriptional Regulations of Junction Proteins in Mammalian estes – Implications on Male Contraceptive Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Fragile X Syndrome: Psychiatric Manifestations, Assessment and Emerging Therapies
Current Psychiatry Reviews Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
Current Pharmacogenomics Imatinib Reduces the Vasculogenic Potential of Plastic Tumor Cells
Current Angiogenesis (Discontinued) Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges
Current Stem Cell Research & Therapy Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry Sudden Cardiac Death in a Young HIV-Positive Man on Effective Antiretroviral Therapy
Current HIV Research